Survival advantage for irinotecan versus best supportive care as second-line chemotherapy in gastric cancer–a randomised phase III study of the Arbeitsgemeinschaft …
PC Thuss-Patience, A Kretzschmar, D Bichev… - European journal of …, 2011 - Elsevier
BACKGROUND: The value of second-line therapy for metastatic gastric cancer is unclear.
So far there are no randomised phase III data comparing second-line chemotherapy to best …
So far there are no randomised phase III data comparing second-line chemotherapy to best …
Liver tumors: comparison of MR imaging with Gd-EOB-DTPA and Gd-DTPA.
TJ Vogl, S Kümmel, R Hammerstingl, M Schellenbeck… - Radiology, 1996 - pubs.rsna.org
PURPOSE: To compare the usefulness of gadolinium ethoxybenzyl
diethylenetriaminepentaacetic acid (Gd-EOB-DTPA) and gadolinium …
diethylenetriaminepentaacetic acid (Gd-EOB-DTPA) and gadolinium …
[HTML][HTML] Extended surgical resection for xanthogranulomatous cholecystitis mimicking advanced gallbladder carcinoma: a case report and review of literature
A Spinelli, G Schumacher, A Pascher… - World journal of …, 2006 - ncbi.nlm.nih.gov
Xanthogranulomatous cholecystitis (XGC) is a destructive inflammatory disease of the
gallbladder, rarely involving adjacent organs and mimicking an advanced gallbladder …
gallbladder, rarely involving adjacent organs and mimicking an advanced gallbladder …
The physiological estrogen metabolite 2-methoxyestradiol reduces tumor growth and induces apoptosis in human solid tumors
G Schumacher, P Neuhaus - Journal of cancer research and clinical …, 2001 - Springer
Methoxyestradiol (2-ME) is a physiological metabolite of estrogen, which is excreted with the
urine. In contrast to most estrogens, tumor growth-inhibiting effects were observed. Further …
urine. In contrast to most estrogens, tumor growth-inhibiting effects were observed. Further …
[PDF][PDF] Trends and experiences in liver retransplantation over 15 years
R Pfitzmann, B Benscheidt, JM Langrehr… - Liver …, 2007 - Wiley Online Library
Compared to primary liver transplantation (LT), the inferior results in the outcome of liver
retransplantation (re‐LT) continue to be a major challenge. The purpose of this study was to …
retransplantation (re‐LT) continue to be a major challenge. The purpose of this study was to …
Biliary reconstruction using a side-to-side choledochocholedochostomy with or without T-tube in deceased donor liver transplantation: a prospective randomized trial
S Weiss, SC Schmidt, F Ulrich, A Pascher… - Annals of …, 2009 - journals.lww.com
Objective: The biliary anastomosis is still one of the major causes for morbidity after
orthotopic liver transplantation. The optimal method of reconstruction remains controversial …
orthotopic liver transplantation. The optimal method of reconstruction remains controversial …
Management of esophageal perforations
SC Schmidt, S Strauch, T Rösch… - Surgical …, 2010 - Springer
Background Esophageal perforations remain a life-threatening event requiring rapid
diagnosis and treatment. Surgical repair and interventional endoscopic or conservative …
diagnosis and treatment. Surgical repair and interventional endoscopic or conservative …
Outcomes of liver transplantation in 490 patients with hepatocellular carcinoma: validation of a uniform staging after surgical treatment
JN Vauthey, D Ribero, EK Abdalla, S Jonas… - Journal of the American …, 2007 - Elsevier
BACKGROUND: The aim of this study was to compare the ability of staging systems
(American Joint Committee on Cancer/Union Internationale contre le Cancer [AJCC/UICC] …
(American Joint Committee on Cancer/Union Internationale contre le Cancer [AJCC/UICC] …
Symptomatic lymphoceles after kidney transplantation–multivariate analysis of risk factors and outcome after laparoscopic fenestration
F Ulrich, S Niedzwiecki, P Fikatas… - Clinical …, 2010 - Wiley Online Library
Ulrich F, Niedzwiecki S, Fikatas P, Nebrig M, Schmidt SC, Kohler S, Weiss S, Schumacher G,
Pascher A, Reinke P, Tullius SG, Pratschke J. Symptomatic lymphoceles after kidney …
Pascher A, Reinke P, Tullius SG, Pratschke J. Symptomatic lymphoceles after kidney …
Potent antitumor activity of 2-methoxyestradiol in human pancreatic cancer cell lines
G Schumacher, M Kataoka, JA Roth… - Clinical cancer …, 1999 - AACR
We examined the effect of 2-methoxyestradiol (2-ME) on the growth and tumorigenesis of
human pancreatic cancer cells. 2-ME inhibited the growth of these cell lines (50–90%) in a …
human pancreatic cancer cells. 2-ME inhibited the growth of these cell lines (50–90%) in a …